Dr. Gary Gershony, MD

Dr. Gershony practices at Baywell Health, West Oakland in Oakland, California.

Dr. Gershony's NPI, 1821095134, was assigned on June 30, 2005. Dr. Gershony graduated from University of Toronto Faculty of Medicine in 1979. Dr. Gershony holds California license G47523.

Dr. Gershony's primary practice is Baywell Health, West Oakland, at 700 Adeline St, Oakland, CA 94607 in Alameda County. The practice phone is (510) 835-9610.

Dr. Gershony's primary practice is Baywell Health, West Oakland in Oakland, California. Dr. Gershony is also affiliated with Alta Bates Summit Medical Center. The medical group on file is Baywell Health. Dmand AI also links Dr. Gershony to 1 more hospital and 3 medical groups, each named with a free account. Dr. Gershony's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gershony practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Gershony's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Gershony is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Gershony's licenses on file in 3 states: California, Oklahoma and Georgia.

CMS data shows 15 Medicare services from Dr. Gershony across 1 procedure code in 2024, for 17 Medicare patients. Medicare paid $139 for them. Every service was in an office.

CMS counts 17 Medicare patients who saw Dr. Gershony in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. 100% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gershony's median patient age at 70, with 49% women.

In 2024, Dr. Gershony wrote 310 Medicare Part D claims for 41 patients. 80% of them were for generic drugs. CMS names the drug for 211 of them, across 10 drugs with 11 or more claims each, at $36,207 in total drug cost. In 2023, CMS named 68 claims across 4 drugs.

Dr. Gershony accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Gershony, published from 2013 to 2015. 2013 was the busiest year, with 2. The most frequent topics are Angioplasty, Balloon, Coronary, Coronary Angiography and Equipment Design. Dr. Gershony has published most often in Cathet Cardiovasc Diagn. Dr. Gershony's most frequent co-authors are Mary Beth Cishek, MD, Hassan Mohamed Hussain, MD and Lawrence J. Laslett, MD.

Dmand AI links Dr. Gershony to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Coronary Restenosis, Coronary Stenosis and Ventricular Outflow Obstruction. Abbott Medical Devices sponsors the most, 3.

CMS Open Payments shows 62 general payments to Dr. Gershony from 15 drug and device companies from 2016 to 2022. Gifts make up the largest share, 44% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $3,990.

Dr. Gershony graduated from University of Toronto Faculty of Medicine in 1979.

Dr. Gershony is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.